Copyright Reports & Markets. All rights reserved.

Global Gestational Diabetes Treatment Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Gestational Diabetes Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Insulin
    • 1.2.3 SGLT-2 Inhibitors
    • 1.2.4 Alpha-glucosidase Inhibitors
    • 1.2.5 Others
  • 1.3 Market by Application
    • 1.3.1 Global Gestational Diabetes Treatment Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Hospital Pharmacies
    • 1.3.3 Retail Pharmacies
    • 1.3.4 Online Pharmacies
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Gestational Diabetes Treatment Market Perspective (2016-2027)
  • 2.2 Gestational Diabetes Treatment Growth Trends by Regions
    • 2.2.1 Gestational Diabetes Treatment Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Gestational Diabetes Treatment Historic Market Share by Regions (2016-2021)
    • 2.2.3 Gestational Diabetes Treatment Forecasted Market Size by Regions (2022-2027)
  • 2.3 Gestational Diabetes Treatment Industry Dynamic
    • 2.3.1 Gestational Diabetes Treatment Market Trends
    • 2.3.2 Gestational Diabetes Treatment Market Drivers
    • 2.3.3 Gestational Diabetes Treatment Market Challenges
    • 2.3.4 Gestational Diabetes Treatment Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Gestational Diabetes Treatment Players by Revenue
    • 3.1.1 Global Top Gestational Diabetes Treatment Players by Revenue (2016-2021)
    • 3.1.2 Global Gestational Diabetes Treatment Revenue Market Share by Players (2016-2021)
  • 3.2 Global Gestational Diabetes Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Gestational Diabetes Treatment Revenue
  • 3.4 Global Gestational Diabetes Treatment Market Concentration Ratio
    • 3.4.1 Global Gestational Diabetes Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Gestational Diabetes Treatment Revenue in 2020
  • 3.5 Gestational Diabetes Treatment Key Players Head office and Area Served
  • 3.6 Key Players Gestational Diabetes Treatment Product Solution and Service
  • 3.7 Date of Enter into Gestational Diabetes Treatment Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Gestational Diabetes Treatment Breakdown Data by Type

  • 4.1 Global Gestational Diabetes Treatment Historic Market Size by Type (2016-2021)
  • 4.2 Global Gestational Diabetes Treatment Forecasted Market Size by Type (2022-2027)

5 Gestational Diabetes Treatment Breakdown Data by Application

  • 5.1 Global Gestational Diabetes Treatment Historic Market Size by Application (2016-2021)
  • 5.2 Global Gestational Diabetes Treatment Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Gestational Diabetes Treatment Market Size (2016-2027)
  • 6.2 North America Gestational Diabetes Treatment Market Size by Type
    • 6.2.1 North America Gestational Diabetes Treatment Market Size by Type (2016-2021)
    • 6.2.2 North America Gestational Diabetes Treatment Market Size by Type (2022-2027)
    • 6.2.3 North America Gestational Diabetes Treatment Market Size by Type (2016-2027)
  • 6.3 North America Gestational Diabetes Treatment Market Size by Application
    • 6.3.1 North America Gestational Diabetes Treatment Market Size by Application (2016-2021)
    • 6.3.2 North America Gestational Diabetes Treatment Market Size by Application (2022-2027)
    • 6.3.3 North America Gestational Diabetes Treatment Market Size by Application (2016-2027)
  • 6.4 North America Gestational Diabetes Treatment Market Size by Country
    • 6.4.1 North America Gestational Diabetes Treatment Market Size by Country (2016-2021)
    • 6.4.2 North America Gestational Diabetes Treatment Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Gestational Diabetes Treatment Market Size (2016-2027)
  • 7.2 Europe Gestational Diabetes Treatment Market Size by Type
    • 7.2.1 Europe Gestational Diabetes Treatment Market Size by Type (2016-2021)
    • 7.2.2 Europe Gestational Diabetes Treatment Market Size by Type (2022-2027)
    • 7.2.3 Europe Gestational Diabetes Treatment Market Size by Type (2016-2027)
  • 7.3 Europe Gestational Diabetes Treatment Market Size by Application
    • 7.3.1 Europe Gestational Diabetes Treatment Market Size by Application (2016-2021)
    • 7.3.2 Europe Gestational Diabetes Treatment Market Size by Application (2022-2027)
    • 7.3.3 Europe Gestational Diabetes Treatment Market Size by Application (2016-2027)
  • 7.4 Europe Gestational Diabetes Treatment Market Size by Country
    • 7.4.1 Europe Gestational Diabetes Treatment Market Size by Country (2016-2021)
    • 7.4.2 Europe Gestational Diabetes Treatment Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Gestational Diabetes Treatment Market Size (2016-2027)
  • 8.2 Asia-Pacific Gestational Diabetes Treatment Market Size by Type
    • 8.2.1 Asia-Pacific Gestational Diabetes Treatment Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Gestational Diabetes Treatment Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Gestational Diabetes Treatment Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Gestational Diabetes Treatment Market Size by Application
    • 8.3.1 Asia-Pacific Gestational Diabetes Treatment Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Gestational Diabetes Treatment Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Gestational Diabetes Treatment Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Gestational Diabetes Treatment Market Size by Region
    • 8.4.1 Asia-Pacific Gestational Diabetes Treatment Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Gestational Diabetes Treatment Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Gestational Diabetes Treatment Market Size (2016-2027)
  • 9.2 Latin America Gestational Diabetes Treatment Market Size by Type
    • 9.2.1 Latin America Gestational Diabetes Treatment Market Size by Type (2016-2021)
    • 9.2.2 Latin America Gestational Diabetes Treatment Market Size by Type (2022-2027)
    • 9.2.3 Latin America Gestational Diabetes Treatment Market Size by Type (2016-2027)
  • 9.3 Latin America Gestational Diabetes Treatment Market Size by Application
    • 9.3.1 Latin America Gestational Diabetes Treatment Market Size by Application (2016-2021)
    • 9.3.2 Latin America Gestational Diabetes Treatment Market Size by Application (2022-2027)
    • 9.3.3 Latin America Gestational Diabetes Treatment Market Size by Application (2016-2027)
  • 9.4 Latin America Gestational Diabetes Treatment Market Size by Country
    • 9.4.1 Latin America Gestational Diabetes Treatment Market Size by Country (2016-2021)
    • 9.4.2 Latin America Gestational Diabetes Treatment Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Gestational Diabetes Treatment Market Size (2016-2027)
  • 10.2 Middle East & Africa Gestational Diabetes Treatment Market Size by Type
    • 10.2.1 Middle East & Africa Gestational Diabetes Treatment Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Gestational Diabetes Treatment Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Gestational Diabetes Treatment Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Gestational Diabetes Treatment Market Size by Application
    • 10.3.1 Middle East & Africa Gestational Diabetes Treatment Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Gestational Diabetes Treatment Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Gestational Diabetes Treatment Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Gestational Diabetes Treatment Market Size by Country
    • 10.4.1 Middle East & Africa Gestational Diabetes Treatment Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Gestational Diabetes Treatment Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Biocon Limited
    • 11.1.1 Biocon Limited Company Details
    • 11.1.2 Biocon Limited Business Overview
    • 11.1.3 Biocon Limited Gestational Diabetes Treatment Introduction
    • 11.1.4 Biocon Limited Revenue in Gestational Diabetes Treatment Business (2016-2021)
    • 11.1.5 Biocon Limited Recent Development
  • 11.2 Eli Lilly
    • 11.2.1 Eli Lilly Company Details
    • 11.2.2 Eli Lilly Business Overview
    • 11.2.3 Eli Lilly Gestational Diabetes Treatment Introduction
    • 11.2.4 Eli Lilly Revenue in Gestational Diabetes Treatment Business (2016-2021)
    • 11.2.5 Eli Lilly Recent Development
  • 11.3 Novo Nordisk
    • 11.3.1 Novo Nordisk Company Details
    • 11.3.2 Novo Nordisk Business Overview
    • 11.3.3 Novo Nordisk Gestational Diabetes Treatment Introduction
    • 11.3.4 Novo Nordisk Revenue in Gestational Diabetes Treatment Business (2016-2021)
    • 11.3.5 Novo Nordisk Recent Development
  • 11.4 Boehringer Ingelheim GmbH
    • 11.4.1 Boehringer Ingelheim GmbH Company Details
    • 11.4.2 Boehringer Ingelheim GmbH Business Overview
    • 11.4.3 Boehringer Ingelheim GmbH Gestational Diabetes Treatment Introduction
    • 11.4.4 Boehringer Ingelheim GmbH Revenue in Gestational Diabetes Treatment Business (2016-2021)
    • 11.4.5 Boehringer Ingelheim GmbH Recent Development
  • 11.5 Sanofi S.A.
    • 11.5.1 Sanofi S.A. Company Details
    • 11.5.2 Sanofi S.A. Business Overview
    • 11.5.3 Sanofi S.A. Gestational Diabetes Treatment Introduction
    • 11.5.4 Sanofi S.A. Revenue in Gestational Diabetes Treatment Business (2016-2021)
    • 11.5.5 Sanofi S.A. Recent Development
  • 11.6 Sun Pharmaceutical Industries Limited
    • 11.6.1 Sun Pharmaceutical Industries Limited Company Details
    • 11.6.2 Sun Pharmaceutical Industries Limited Business Overview
    • 11.6.3 Sun Pharmaceutical Industries Limited Gestational Diabetes Treatment Introduction
    • 11.6.4 Sun Pharmaceutical Industries Limited Revenue in Gestational Diabetes Treatment Business (2016-2021)
    • 11.6.5 Sun Pharmaceutical Industries Limited Recent Development
  • 11.7 Merck
    • 11.7.1 Merck Company Details
    • 11.7.2 Merck Business Overview
    • 11.7.3 Merck Gestational Diabetes Treatment Introduction
    • 11.7.4 Merck Revenue in Gestational Diabetes Treatment Business (2016-2021)
    • 11.7.5 Merck Recent Development
  • 11.8 Novartis
    • 11.8.1 Novartis Company Details
    • 11.8.2 Novartis Business Overview
    • 11.8.3 Novartis Gestational Diabetes Treatment Introduction
    • 11.8.4 Novartis Revenue in Gestational Diabetes Treatment Business (2016-2021)
    • 11.8.5 Novartis Recent Development
  • 11.9 Adocia
    • 11.9.1 Adocia Company Details
    • 11.9.2 Adocia Business Overview
    • 11.9.3 Adocia Gestational Diabetes Treatment Introduction
    • 11.9.4 Adocia Revenue in Gestational Diabetes Treatment Business (2016-2021)
    • 11.9.5 Adocia Recent Development
  • 11.10 Peptron
    • 11.10.1 Peptron Company Details
    • 11.10.2 Peptron Business Overview
    • 11.10.3 Peptron Gestational Diabetes Treatment Introduction
    • 11.10.4 Peptron Revenue in Gestational Diabetes Treatment Business (2016-2021)
    • 11.10.5 Peptron Recent Development
  • 11.11 AstraZeneca plc
    • 11.11.1 AstraZeneca plc Company Details
    • 11.11.2 AstraZeneca plc Business Overview
    • 11.11.3 AstraZeneca plc Gestational Diabetes Treatment Introduction
    • 11.11.4 AstraZeneca plc Revenue in Gestational Diabetes Treatment Business (2016-2021)
    • 11.11.5 AstraZeneca plc Recent Development
  • 11.12 Pfizer, Inc
    • 11.12.1 Pfizer, Inc Company Details
    • 11.12.2 Pfizer, Inc Business Overview
    • 11.12.3 Pfizer, Inc Gestational Diabetes Treatment Introduction
    • 11.12.4 Pfizer, Inc Revenue in Gestational Diabetes Treatment Business (2016-2021)
    • 11.12.5 Pfizer, Inc Recent Development
  • 11.13 Takeda Pharmaceutical Company Ltd
    • 11.13.1 Takeda Pharmaceutical Company Ltd Company Details
    • 11.13.2 Takeda Pharmaceutical Company Ltd Business Overview
    • 11.13.3 Takeda Pharmaceutical Company Ltd Gestational Diabetes Treatment Introduction
    • 11.13.4 Takeda Pharmaceutical Company Ltd Revenue in Gestational Diabetes Treatment Business (2016-2021)
    • 11.13.5 Takeda Pharmaceutical Company Ltd Recent Development
  • 11.14 Abbott
    • 11.14.1 Abbott Company Details
    • 11.14.2 Abbott Business Overview
    • 11.14.3 Abbott Gestational Diabetes Treatment Introduction
    • 11.14.4 Abbott Revenue in Gestational Diabetes Treatment Business (2016-2021)
    • 11.14.5 Abbott Recent Development
  • 11.15 Antares Pharma
    • 11.15.1 Antares Pharma Company Details
    • 11.15.2 Antares Pharma Business Overview
    • 11.15.3 Antares Pharma Gestational Diabetes Treatment Introduction
    • 11.15.4 Antares Pharma Revenue in Gestational Diabetes Treatment Business (2016-2021)
    • 11.15.5 Antares Pharma Recent Development
  • 11.16 INJEX Pharma AG
    • 11.16.1 INJEX Pharma AG Company Details
    • 11.16.2 INJEX Pharma AG Business Overview
    • 11.16.3 INJEX Pharma AG Gestational Diabetes Treatment Introduction
    • 11.16.4 INJEX Pharma AG Revenue in Gestational Diabetes Treatment Business (2016-2021)
    • 11.16.5 INJEX Pharma AG Recent Development
  • 11.17 Daiichi Sankyo
    • 11.17.1 Daiichi Sankyo Company Details
    • 11.17.2 Daiichi Sankyo Business Overview
    • 11.17.3 Daiichi Sankyo Gestational Diabetes Treatment Introduction
    • 11.17.4 Daiichi Sankyo Revenue in Gestational Diabetes Treatment Business (2016-2021)
    • 11.17.5 Daiichi Sankyo Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Gestational Diabetes Treatment Scope and Market Size
    Gestational Diabetes Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gestational Diabetes Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Insulin
    SGLT-2 Inhibitors
    Alpha-glucosidase Inhibitors
    Others

    Segment by Application
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Biocon Limited
    Eli Lilly
    Novo Nordisk
    Boehringer Ingelheim GmbH
    Sanofi S.A.
    Sun Pharmaceutical Industries Limited
    Merck
    Novartis
    Adocia
    Peptron
    AstraZeneca plc
    Pfizer, Inc
    Takeda Pharmaceutical Company Ltd
    Abbott
    Antares Pharma
    INJEX Pharma AG
    Daiichi Sankyo

    Buy now